COMDTINST 6230.5A
6 DEC 1993
b.
Commanders (k), Maintenance and Logistics Commands. Advise and assist line
commanders and health services personnel on all aspects of malaria prevention and
control, including malaria-risk assessments for geographic areas of deployment or travel.
c.
Unit commanding officers and officers-in-charge. Commanding officers and officers in
charge whose units are subject to deployment to or travel through malaria- risk areas shall:
(1)
Ensure maintenance of appropriate malaria prevention and control supplies before,
during, and after deployment or visits to malaria-risk areas.
(2)
Ensure all personnel receive adequate instruction in individual malaria prevention
and control before deployment to or travel through malaria-risk areas.
(3)
Ensure all personnel deployed to or traveling through malaria-risk areas have had a
screening test for erythrocyte glucose-6-phosphate dehydrogenase (G-6-PD). G-6-
PD testing is mandatory for all personnel with no record of testing prior to
assignments afloat or to malaria endemic areas. A copy of their G-6-PD test result
shall be placed in the health record of each individual tested. The result shall be
entered on the top line of the Problem Summary List (NAVMED 6150/20). Once a
G-6-PD test has been performed and the results recorded, the test need never be
repeated. Any person who is G-6-PD deficient has a risk of hemolysis associated
with taking for chemoprophylaxis or treatment. Accordingly, those persons who
are deployed to or traveling through a malaria-risk area must be identified and
evaluated by medical personnel as to the need for special chemoprophylaxis and
treatment protocols.
(4)
Ensure appropriate documentation in health records of personnel who receive
malaria chemoprophylaxis.
(5)
Report suspected or confirmed malaria cases in Disease Alert Reports (DAR) (RCN
6000-4) via message (UNCLAS FOUO classification) of letter in accordance with
Chapter 7, Medical Manual, COMDTINST M6000.1(series). A malaria DAR shall
include the patient's itinerary during the previous three months and the types and
duration of any chemoprophylaxis or treatment medications taken.
/s/ ALAN M. STEINMAN
Chief, Office of Health and Safety
Encl: (1) Recommended Supplies for Malaria Prevention and Treatment Programs
5
Previous Page
